Sign In
Buy INGN
$6.45
+0.0300 (+0.467%)
At Close: Jul 31, 2026
Inogen (INGN) Q4 Earnings Beat Estimates, Revenues Lag
12:49pm, Friday, 24'th Feb 2023
Inogen's (INGN) fourth-quarter results benefit from higher revenues in its domestic business-to-business sales channel.
Inogen Inc. (INGN) Q4 2022 Earnings Call Transcript
09:33pm, Thursday, 23'rd Feb 2023
Inogen Inc. (NASDAQ:INGN ) Q4 2022 Results Conference Call February 23, 2023 5:00 PM ET Company Participants Agnes Lee - SVP of IR and Strategic Planning Nabil Shabshab - President and CEO Kristin Cal
3 Reasons to Retain Inogen (INGN) Stock in Your Portfolio
07:32am, Wednesday, 22'nd Feb 2023
Investors continue to be optimistic about Inogen (INGN) on its potential in the POC space and a strong product portfolio.
Inogen (INGN) Announces Solid Preliminary Q4 Revenues
09:47am, Friday, 13'th Jan 2023
Inogen's (INGN) revenue growth in the fourth quarter is likely to have been boosted by continued strength in its product sales.
3 Reasons to Retain Inogen (INGN) Stock in Your Portfolio
12:02pm, Tuesday, 27'th Dec 2022
Investors continue to be optimistic about Inogen (INGN) on its potential in the POC space and a strong product portfolio.
3 Beaten-Down MedTech Stocks Poised for a Turnaround in 2023
09:47am, Friday, 09'th Dec 2022
Here are some dirt-cheap MedTech value stocks - DYNT, INGN, AVNS - which are expected to provide long-term gains.
Inogen (INGN) Q3 Earnings and Revenues Beat Estimates
12:48pm, Thursday, 03'rd Nov 2022
Inogen's (INGN) third-quarter results benefit from higher revenues in its domestic business-to-business sales channel.
Inogen, Inc. (INGN) Q3 2022 Earnings Call Transcript
10:49am, Wednesday, 02'nd Nov 2022
Inogen, Inc. (NASDAQ:INGN ) Q3 2022 Results Conference Call November 2, 2022 8:00 AM ET Company Participants Agnes Lee - SVP of IR and Strategic Planning Nabil Shabshab - President and CEO Kristin Cal
3 Reasons to Add Inogen (INGN) Stock to Your Portfolio Now
12:48pm, Monday, 17'th Oct 2022
Investors continue to be optimistic about Inogen (INGN) on its potential in the POC space and a strong product portfolio.
Inogen to Announce Third Quarter 2022 Financial Results on November 2, 2022
08:30am, Wednesday, 05'th Oct 2022
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will issue third
Inogen: Little Breathing Room
06:49am, Thursday, 15'th Sep 2022
Inogen has been a long-term growth story which has seen real execution challenges in recent years. Current supply chain woes make up for a tough margin picture, yet operational issues have been seen f
3 Reasons to Hold Inogen (INGN) Stock in Your Portfolio
03:03pm, Tuesday, 13'th Sep 2022
Investors continue to be optimistic about Inogen (INGN) on its potential in the POC space and a strong product portfolio.
Inogen: Structural, Supply Chain Headwinds Remain
10:22am, Tuesday, 13'th Sep 2022
Inogen came in with a mixed set of numbers, however, longer-term structural headwinds remain in situ. The hold rating on INGN remains intact following Q2 earnings, and I've noticed similar themed risk
Inogen (INGN) Q2 Earnings and Revenues Beat Estimates
11:19am, Monday, 08'th Aug 2022
Inogen's (INGN) second-quarter results benefit from higher revenues in its international business-to-business sales channel.
Inogen, Inc. (INGN) CEO Nabil Shabshab on Q2 2022 Results - Earnings Call Transcript
12:04pm, Sunday, 07'th Aug 2022
Inogen, Inc. (NASDAQ:INGN ) Q2 2022 Earnings Conference Call August 4, 2022 5:00 PM ET Company Participants Agnes Lee - SVP of IR and Strategic Planning Nabil Shabshab - President and CEO Kristin Calt
